Ovarian Cancer

Attachment Insecurity and Depression, Anxiety in Ovarian Cancer Patient Partner-Caregivers

By

Jessica Nye, PhD

Publish Date September 24, 2021

A cross-sectional study sought to determine how caregiving responsibilities affect mental health of partner-caregivers.

Avelumab Provides No Benefit as Frontline Therapy or Maintenance in Ovarian Cancer

By

Andrea S. Blevins Primeau, PhD, MBA

Publish Date August 19, 2021

Avelumab did not improve progression-free survival when given concurrently with chemotherapy or as maintenance.

Updated Data Confirm Safety of Olaparib Maintenance in Advanced Ovarian Cancer

By

Sucharita Mistry, PhD

Publish Date August 18, 2021

Most adverse events in the olaparib arm were manageable with supportive treatment or dose modifications.

Use of PARP Inhibitor Maintenance on the Rise in Platinum-Sensitive, Recurrent Ovarian Cancer

By

Sucharita Mistry, PhD

Publish Date August 17, 2021

PARP inhibitor use increased regardless of BRCA mutation status.

Avelumab Doesn’t Improve Survival in Platinum-Refractory Ovarian Cancer

By

Sucharita Mistry, PhD

Publish Date July 21, 2021

There was no improvement in progression-free or overall survival.

Ovarian Cancer Clinical Trials

Clinical Trial: Specimen and Data Study for Ovarian Cancer Early Detection and Prevention

Clinical Trial: Prophylactic Salpingectomy With Delayed Oophorectomy

Clinical Trial: Interactive Educational Website for Women With Ovarian Cancer & Caregivers

Clinical Trial: Veliparib and Topotecan for Relapsed Ovarian Cancer With Negative or Unknown BRCA Status

Clinical Trial: AZD2281 Plus Carboplatin to Treat Breast and Ovarian Cancer